drugset / Trial / NCT06791083
Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
To observe and evaluate the neoadjuvant treatment of Envafolimab combined with Fruquintinib and chemotherapy for locally advanced gastric/gastroesophageal junction carcinoma
Timeline
- Start
- 2024-06-20
- Primary completion
- 2025-12
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Envafolimab | Monoclonal antibody | 150 mg/m2 | Other |
| Subject | Fruquintinib | Small molecule | 5 mg | Oral |